Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Menten AI's investors include Alumni Ventures, Khosla Ventures, Y Combinator, Uncork Capital, Creative Destruction Lab.
Menten AI is headquartered in Palo Alto, United States.
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Menten AI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Menten AI — Funding & Investors." VCBacked, May 5, 2023, https://www.vcbacked.co/company/menten-ai. Accessed November 13, 2026.
VCBacked. (2023). Menten AI — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/menten-ai
{{cite web |title=Menten AI — Funding & Investors |url=https://www.vcbacked.co/company/menten-ai |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Menten AI? Request a listing update